![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
WC Glasgow and TE Eling
Laboratory of Molecular Biophysics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
One response of BALB/c 3T3 cells to epidermal growth factor (EGF) is the release and subsequent metabolism of arachidonic acid. Prostaglandins generated from EGF treatment appear to play a role in the mitogenic signal. Lipoxygenase inhibitors (nordihydroguaiaretic acid and 5,8,11,14-eicosatetraynoic acid) were previously shown to be very effective in blocking EGF-stimulated DNA synthesis; however, only low levels of lipoxygenase-derived arachidonate metabolites were detected. In an extension of these investigations, we have now found that EGF stimulates lipoxygenase metabolites of linoleic acid in BALB/c 3T3 fibroblasts. In the presence of EGF (10 ng/ml), the cells converted 10-15% of exogenous linoleic acid (10 microM) to hydroxy fatty acids that were isolated on reverse phase high performance liquid chromatography. No linoleate metabolites were detected in the absence of EGF. The isolated compounds were characterized further by straight phase high performance liquid chromatography, UV spectroscopy, and gas chromatography-mass spectrometry analyses, and they were identified as 13-hydroxyoctadecadienoic acid and 9-hydroxyoctadecadienoic acid. The hydroxy metabolites and their hydroperoxy precursors produced a 2- to 4- fold potentiation of EGF-stimulated [3H]thymidine incorporation in BALB/c 3T3 cells. These linoleate derivatives stimulated DNA synthesis at concentration ranges of 10(-8) to 10(-6) M. Thus, linoleic acid metabolism might be an important element in the EGF-regulated cascade of biochemical events leading to fibroblast mitogenesis.
This article has been cited by other articles:
|
|
 |
|
  I. Shureiqi and S. M. Lippman Lipoxygenase Modulation to Reverse Carcinogenesis Cancer Res., September 1, 2001; 61(17): 6307 - 6312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shureiqi, K. J. Wojno, J. A. Poore, R. G. Reddy, M. J. Moussalli, S. A. Spindler, J. K. Greenson, D. Normolle, A. A.K. Hasan, T. S. Lawrence, et al. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers Carcinogenesis, October 1, 1999; 20(10): 1985 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Sauer, R. T. Dauchy, D. E. Blask, B. J. Armstrong, and S. Scalici 13-Hydroxyoctadecadienoic Acid Is the Mitogenic Signal for Linoleic Acid-dependent Growth in Rat Hepatoma 7288CTC in Vivo Cancer Res., September 1, 1999; 59(18): 4688 - 4692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Glasgow, R. Hui, A. L. Everhart, S. P. Jayawickreme, J. Angerman-Stewart, B.-B. Han, and T. E. Eling The Linoleic Acid Metabolite, (13S)-Hydroperoxyoctadecadienoic Acid, Augments the Epidermal Growth Factor Receptor Signaling Pathway by Attenuation of Receptor Dephosphorylation. DIFFERENTIAL RESPONSE IN SYRIAN HAMSTER EMBRYO TUMOR SUPPRESSOR PHENOTYPES J. Biol. Chem., August 1, 1997; 272(31): 19269 - 19276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Natarajan, R. Esworthy, W. Bai, J.-L. Gu, S. Wilczynski, and J. Nadler Increased 12-Lipoxygenase Expression in Breast Cancer Tissues and Cells. Regulation by Epidermal Growth Factor J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1790 - 1798. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
